Observations placeholder

Exjade

Identifier

018982

Type of Spiritual Experience

Hallucination

Number of hallucinations: 43

Background

A description of the experience

Deferasirox (marketed as Exjade, Desirox, Defrijet, Desifer...) is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.   It is the first oral medication approved in the USA for this purpose.

It was approved by the United States Food and Drug Administration (FDA) in November 2005] According to FDA (May 2007), renal failure and cytopenias have been reported in patients receiving deferasirox oral suspension tablets. It is approved in the European Union by the European Medicines Agency (EMA) for children 6 years and older for chronic iron overload from repeated blood transfusions.

On Jan, 03, 2017 24,441 people reported to have side effects when taking Exjade.
Among them, 43 people (0.18%) have Hallucination

Time on Exjade when people have Hallucination:

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Hallucination46.15%53.85%0.00%0.00%0.00%0.00%0.00%

 

On Nov, 21, 2015: 18,158 people reported to have side effects when taking Exjade. Among them, 4,165 people (22.94%) have Death.

Time on Exjade when people have Death  :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death15.95%34.59%19.35%15.41%13.80%0.90%0.00%

 

The source of the experience

eHealthme

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Activities

Overloads

Iron imbalance

Suppressions

Chelation agents

Commonsteps

References